Name | Type | Posted | Actions |
|---|---|---|---|
Exhibit D 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit C 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit B 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit A 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit E 6Mar25.docx | DOCX | Mar 6, 2025 | |
HT940625R0004 Conformed P00003.pdf | Mar 6, 2025 | ||
Exhibit E 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit D 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit C 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit B 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit A 25Feb25.docx | DOCX | Feb 25, 2025 | |
HT940625R0004 Conformed P00002.pdf | Feb 25, 2025 | ||
HT940625R0004 Conformed.pdf | Feb 13, 2025 | ||
Exhibit E.docx | DOCX | Feb 13, 2025 | |
Exhibit D.docx | DOCX | Feb 13, 2025 | |
Exhibit C.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 13, 2025 | |
Exhibit A.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 10, 2025 | |
Exhibit C.docx | DOCX | Feb 10, 2025 | |
Exhibit D.docx | DOCX | Feb 10, 2025 | |
Exhibit E.docx | DOCX | Feb 10, 2025 | |
HT940625R0004.pdf | Feb 10, 2025 | ||
Exhibit A.docx | DOCX | Feb 10, 2025 |
Radiopharmaceuticals - Naval Medical Center Portsmouth
Contact and place of performance
Carol Uebelacker
Portsmouth, VA 23708
USA
Defense Health Agency (DHA) has a requirement for a Firm Fixed Price (FFP) IDIQ supply contract in accordance with FAR Part 12, Commercial Items and FAR Part 13, Simplified Acquisition Procedures for General Nuclear Medicine Radiopharmaceuticals (GNMR) at Naval Medical Center Portsmouth (NMCP) VA. In order to be considered for this requirement, please respond with a completed proposal following the guidelines starting on page 3 of the SF1449.
The Defense Health Agency (DHA) has issued solicitation HT940625R0004 for a firm-fixed-price, indefinite-delivery/indefinite-quantity supply contract. The requirement involves providing general nuclear medicine radiopharmaceuticals to support the Naval Medical Center Portsmouth in Portsmouth, Virginia. This procurement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals.
The agency is conducting this acquisition in accordance with procedures for commercial items and simplified acquisition. Proposals must be submitted by March 11, 2025, following the specific guidelines provided in the solicitation documentation. The administrative record for this notice includes 24 attachments, such as multiple exhibits updated on March 6, 2025, and a conformed copy of the solicitation. Carol Uebelacker serves as the primary point of contact for this requirement.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.